Abiopharma

Revvity - Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

BD To Host Virtual 2026 Annual Meeting of Shareholders

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Taiwan Carbon Nano Technology Corp 🔴 sold 1.3K shares of Ainos, Inc. (AIMD) at $1.86 Transaction Date: Jan 08, 2026 | Filing ID: 001852

Director Glastra Matthijs 🔴 sold 323 shares of NOVANTA INC (NOVT) at $130.14 Transaction Date: Jan 08, 2026 | Filing ID: 000023

Director Hudson Frederick M. 🟡 adjusted position in 0 shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $12.98 Transaction Date: Jan 09, 2026 | Filing ID: 001817

(99% Neutral) Avadel Pharmaceuticals (AVDL) Announces Business Combination

Illumina, Inc. - Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

📋 MARK R MUNCH (Officer) plans to sell 7K shares of Bruker Corporation (at $55.00 each, total $385K) Filed: Jan 12, 2026 | ID: 000324

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

New Form SCHEDULE 13G - Galecto, Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010366 Size: 8 KB

📋 Rogers Erica J. (Ex-Director) plans to sell 10K shares of Sight Sciences, Inc. (at $7.38 each, total $74K) Filed: Jan 12, 2026 | ID: 000260

(90% Positive) BridgeBio Pharma (BBIO) Provides Update on increase for chroni